Sarah Watson
Research Pharmacist, UMC
Photo: Eli Francis on Unsplash
A UMC researcher reviews a book that examines the French pharmacovigilance system through the eyes of patients affected by adverse drug reactions.
I’ve just finished a fascinating book, Effets indésirables: Victimes des médicaments (undesirable effects: victims of drugs) by French freelance journalist, Clotilde Cadu, which delves into the French pharmacovigilance system through the eyes of patients affected by adverse drug reactions. It’s not so often that we come across books on pharmacovigilance themes for a broader audience, so it’s nice to find one as well written as this.
In Effets indésirables: Victimes des médicaments, Cadu revisits several cases of drug-related harm from recent French history from the point of view of the patients. She gives the patients a voice, telling what it was like for those affected by the drugs and how they were perceived and treated by doctors, pharmaceutical companies, and the legal system.
As a researcher, used to dealing with case reports, scientific papers, and statistics, a book like this is an important reminder that there is a real person behind every data point. I believe that keeping that perspective is vital to the quality and relevance of our research. The better we understand what the patients are experiencing, the better we can do our job of improving their safety.
Sarah Watson
Research Pharmacist, UMC
While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions
18 February 2026
Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.
07 April 2026
An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.
30 March 2026